KRAS-mutation status in relation to colorectal cancer survival: the joint impact of correlated tumour markers.

Phipps, A I; Buchanan, D D; Makar, K W; Win, A K; Baron, J A; Lindor, N M; Potter, J D; Newcomb, P A

Phipps, A I; Buchanan, D D; Makar, K W; Win, A K; Baron, J A; Lindor, N M; Potter, J D; Newcomb, P A.

Affiliation

Phipps AI; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA. aphipps@fhcrc.org

Br J Cancer ; 108(8): 1757-64, 2013 Apr 30.

Article in En | MEDLINE | ID: mdl-23511557

Subject(s)

Colorectal Neoplasms/genetics; Genes, ras; Mutation; Adult; Aged; Colorectal Neoplasms/epidemiology; Colorectal Neoplasms/mortality; Female; Humans; Male; Middle Aged; SEER Program; Survival Rate; Washington/epidemiology; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Colorectal Neoplasms / Genes, ras / Mutation Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Br J Cancer Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google